Research Site — Medford, Oregon

Research Site is a clinical research site located in Medford, Oregon, United States 97504.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 90 clinical trials with 8 currently active.

Therapeutic areas: Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis, Diabetes Mellitus, Type 2.

Sponsors: Biogen, AstraZeneca, Pearl Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Medford

Browse all research sites in Oregon · View every site in Medford

• GSK Investigational Site
• Velocity Clinical Research Medford
• Asante Rogue Regional Medical Center
• Novartis Investigative Site
• Clinical Research Institute of Southern Oregon PC
• Providence Medford Medical Center
• Sunstone Medical Research
• Pfizer Investigational Site
• Rogue Valley Medical Center
• Velocity Clinical Research
• Duramed Investigational Site

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 90 clinical trials on record, with 8 currently active. Their work covers Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis, Diabetes Mellitus, Type 2.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.